快速和高度灵敏地检测Mycobacterium tuberculosis使用基于重组酶辅助放大CRISPR-Cas13a系统
Qiao Li1, Nenhan Wang2, Mengdi Pang2,3
1Biobank of Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis & Thoracic Tumor Research Institute, Beijing 101149, China.
Microorganisms
|August 29, 2024
概括
一种新的RAA-CRISPR测定能快速检测出结核病的原因 - - 结核菌菌菌 (MTB). 这种敏感和特定的诊断工具显示出早期结核病诊断的前景,特别是在资源有限的环境中.
科学领域:
- 微生物学 微生物学
- 分子诊断学 分子诊断
- 公共卫生 公共卫生
背景情况:
- 结核病 (TB) 仍然是一个重大的全球卫生挑战.
- 早期和准确的结核病诊断对于有效的治疗和控制至关重要.
- 现有的诊断方法可能在灵敏度,特异性或可访问性方面存在限制.
研究的目的:
- 开发和评估一种用于检测Mycobacterium结核病 (MTB) 的新型快速诊断试验.
- 通过使用各种模板和临床样本来评估开发的试验的灵敏度和特异性.
- 将新试验的性能与现有的诊断工具 (如Xpert MTB/RIF试验) 进行比较.
主要方法:
- 通过将重组酶辅助放大 (RAA) 与CRISPR-Cas13a光相结合,开发一种快速MTB检测试验 (RAA-CRISPR-MTB).
- 通过对重组等离子体,菌根菌株和151个临床标本的测试来评估诊断疗效.
- 通过检测低度的IS6110基因来评估灵敏度,通过对非肺结核菌根 (NTM) 的测试来测试特异性.
主要成果:
- 在RAA-CRISPR测定检测到IS6110基因水平低至1副本/μL (pUC57-6110) 和10副本/μL (H37Rv).
- 没有观察到与非结核真菌菌 (NTM) 的交叉反应.
- 在临床样本中,该试验显示了100%的特异性和69%的灵敏度,超过了Xpert MTB/RIF试验的60%灵敏度.
结论:
- 一个新的RAA-CRISPR测定成功建立了敏感和特定的MTB检测.
- 该测试为早期结核病诊断提供了一个有希望的新工具.
- 由于其性能特征,这种试验特别适合在资源较差的环境中临床使用.
更多相关视频
09:03Field-Deployable Candidatus Liberibacter asiaticus Detection Using Recombinase Polymerase Amplification Combined with CRISPR-Cas12a
Published on: December 23, 2022
2.6K
10:16Author Spotlight: Development of Simplified CRISPR-Based Tests for Rapid Detection of Infectious Diseases
Published on: August 16, 2024
1.1K
相关概念视频
02:53CRISPR and crRNAs
16.9K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
16.9K
01:59CRISPR
49.9K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
49.9K